Skip to main content
Canadian Journal of Pain logoLink to Canadian Journal of Pain
. 2019 Jun 26;3(1):137–147. doi: 10.1080/24740527.2019.1620097

Evaluating the psychometric properties of the Widespread Pain Index and the Symptom Severity Scale in youth with painful conditions

Joanne Dudeney a,b,, Emily F Law a,c, Alagumeena Meyyappan a, Tonya M Palermo a,c, Jennifer A Rabbitts c,d
PMCID: PMC7015535  NIHMSID: NIHMS1529851  PMID: 32051925

ABSTRACT

Background: Assessing features of centralized pain may prove to be clinically meaningful in pediatric populations. However, we are currently limited by the lack of validated pediatric measures.

Aim: We examined the psychometric properties of the Widespread Pain Index (WPI) and Symptom Severity (SS) scale to assess features of centralized pain in youth with painful conditions from three clinical samples: (1) musculoskeletal surgery, (2) headache, and (3) chronic pain.

Methods: Participants were 240 youth aged 10 to 18 years (Mage = 14.8, SD = 1.9) who completed the WPI and SS scale. Subsets of participants also completed additional measures of pain region, pain intensity, quality of life, pain interference, and physical function.

Results: Increased features of centralized pain by age were seen for the WPI (r = 0.27, P < 0.01) and SS scale (r = 0.29, P < 0.01). Expected differences in sex were seen for the WPI (sex: t132 = −3.62, P < 0.01) but not the SS scale (sex: t223 = −1.73, P = 0.09). Reliability for the SS scale was adequate (α = 0.70). Construct validity was demonstrated through relationships between the WPI and pain regions (r = 0.57, P < 0.01) and between the SS scale and quality of life (r = −0.59, P < 0.01) and pain interference (r = 0.56, P < 0.01). Criterion validity was demonstrated by differences on the WPI between the surgery sample and the headache and chronic pain samples (F2,237 = 17.55, P < 0.001). Comprehension of the SS scale items was problematic for some youth.

Conclusions: The WPI showed adequate psychometric properties in youth; however, the SS scale may need to be modified. Our findings support the need to develop psychometrically sound instruments for comprehensive assessment of pain in pediatric samples.

KEYWORDS: chronic pain, child, centralized pain, pain distribution, pain location, widespread pain

Introduction

Pain can modify the central nervous system, so that an individual experiences more pain with less provocation. This process is called “central sensitization” because it involves heightened responsiveness of pain signals in the brain and the spinal cord,1,2 which increases sensitivity to pain. Clinical studies have demonstrated a number of chronic conditions (e.g., fibromyalgia, rheumatologic diseases, chronic pancreatitis, chronic pelvic pain) in which heightened pain responsiveness and greater spatial extent of pain (thought to be phenomena of central sensitization) are part of the pain phenotype.37

Methods such as quantitative sensory testing and brain imaging technologies have typically been used to study mechanisms of central sensitization.8 Research using these modalities has demonstrated heightened pain sensitivity, increased pain facilitation, diminished pain inhibition, and alteration in brain function and structure as markers of central sensitization in adults.911 Similarly, in youth, quantitative sensory testing has identified greater sensitivity to pain for those with conditions such as juvenile idiopathic arthritis, fibromyalgia, and functional abdominal pain, indicating that central sensitization is also part of the pain phenotype in pediatric pain conditions.1214 Recently, researchers have utilized self-report to investigate clinical features of centralized pain, including spatial distribution of pain and cognitive, emotional, and physical symptoms.15,16 Although self-report is an indirect tool to assess central sensitization, it remains the gold standard in pain assessment.8 Indeed, comprehensive assessment of pain, which includes assessment of bodily distribution of pain, is needed to accurately classify both acute and chronic pain.17,18 Valid and reliable self-report measures are essential for characterizing pain features in the clinical setting, particularly in pediatric populations, where objective testing (e.g., quantitative sensory testing or brain imaging) may not be available or feasible. However, a major limiting factor in assessing features of centralized pain in youth via self-report is the lack of validated pediatric measures.

The Widespread Pain Index (WPI) and Symptom Severity (SS) scale is a self-report measure assessing pain distribution (WPI) and the severity of six symptoms, including fatigue, memory difficulties, tiredness, headache, abdominal pain, and depression (SS scale).19,20 The WPI and SS scale was originally developed to classify fibromyalgia in adults using the adapted 2010 American College of Rheumatology fibromyalgia survey criteria2123; however, the combined measure has since been utilized more widely to assess degree of widespread body pain and centralized pain features (e.g., cognitive, emotional, and physical symptoms) in studies of general chronic pain conditions,24,25 and surgical samples.16,26 The few available studies examining features of centralized pain in pediatric populations, as measured by self-report, have used the combined WPI and SS scale.2729 However, the psychometric properties of the WPI and SS scale have not been evaluated in pediatric populations to understand whether the measure is reliable and valid, outside of assessing diagnostic utility in youth with fibromyalgia.29

To address this gap, the aim of the current study was to assess the psychometric properties of the WPI and SS scale in three clinical samples of youth (musculoskeletal surgery, headache, chronic pain) that would be expected to differ in the degree of centralized pain features based on the location, severity, and chronicity of pain. Because the WPI and SS scale was not developed for use in pediatric populations, we were also interested in assessing comprehension of instructions and items. First, based on research showing higher incidence of centralized pain conditions (e.g., widespread pain and juvenile fibromyalgia) in females compared to males and adolescents compared to children,30,31 we expected that higher scores on the WPI and higher SS scales would be shown for females compared to males and older adolescents compared to younger adolescents. Second, we hypothesized that reliability for the SS scale would be demonstrated through strong internal consistency and interitem and item total correlations. Third, based on previous research showing strong relationships between features of centralized pain and pain and quality of life outcomes,28,32,33 we expected to demonstrate construct validity via strong associations between (1) the WPI score and number of pain regions, (2) the SS scale and measures of quality of life and pain interference, and (3) the total score and measures of pain (regions, intensity) and function (quality of life, pain interference, physical function). Fourth, we hypothesized that criterion validity would be demonstrated through significant differences in pain features between clinical samples, which theoretically should have differing levels of features of centralized pain. Specifically, we expected that higher scores on the WPI and higher SS scales would be found for those in the chronic pain and headache groups, when compared to those from the musculoskeletal surgery group, based on prior research demonstrating both persistent pain in multiple locations and heightened pain sensitivity in chronic headache and chronic pain conditions.3436 Finally, we hypothesized that youth would demonstrate adequate comprehension of the WPI and SS scales, based on individual interviews.

Materials and methods

Participants

Participants included 240 youth, 10 to 18 years of age, enrolled in one of three studies at a tertiary children’s hospital in the Pacific Northwest United States. The participants included (1) 89 youth with musculoskeletal conditions scheduled to undergo major musculoskeletal surgery (spinal n = 62; pectus n = 22; other n = 3), (2) 56 youth with frequent or chronic headache as a primary pain complaint (i.e., at least eight or more headache days a month for at least 3 months) and pain in at least one other location, and (3) 97 youth presenting for evaluation of chronic pain; that is, recurrent or persistent pain experienced for at least 3 months (musculoskeletal n = 51; abdominal n = 19; headache n = 19; other n = 8). In recruiting each of the three samples (musculoskeletal surgery, headache, chronic pain), research teams identified potentially eligible participants from the surgery clinic and operating room schedules, after new patient evaluations in a pediatric neurology clinic or from the community, and after new patient evaluations in an interdisciplinary pediatric pain clinic, respectively. Data reported in the current study were collected during the baseline assessment (pretreatment) phase of each study. Exclusion criteria were consistent across studies and included (1) the presence of a serious medical comorbidity (e.g., cancer), (2) a severe developmental delay, or (3) the youth or parent was non-English speaking.

Procedures

The local institutional review board approved all procedures for the three studies. Across studies, research assistants screened potentially eligible youth via telephone; provided eligible families with electronic copies of the consent, assent, and HIPPA forms; and obtained verbal consent and assent via telephone prior to starting any study procedures. All participants completed survey measures online, via a secure Research Electronic Data Capture link.37 A subset of participants (n = 70) from the surgery sample completed a pain region body map on paper. Participants received gift cards for completion of online assessments.

Research staff (MM, JD) individually contacted a sample of participants and conducted a brief telephone interview to assess comprehension of the WPI and SS scales. We employed convenience sampling, in which we only contacted participants for the comprehension interview if they had completed the measure within the past 10 weeks; thus, we were unable to conduct an equal number of interviews across the samples. Eleven participants completed the interview: six from the surgery sample, four from the headache sample, and two from the chronic pain sample. We found no demographic differences (e.g., age, sex, ethnicity, parent education) between the participants interviewed and the full sample (all Ps > 0.05).

Measures

Widespread Pain Index and Symptom Severity Scale

The WPI and SS scale is a 27-item self-report measure used to assess bodily distribution of pain and to specifically quantify the degree of widespread body pain and assess for centralized pain features (e.g., cognitive, emotional, and physical symptoms).19,20 It consists of two scales, one assessing pain distribution from focal to widespread (WPI) and the other assessing the presence and severity of symptoms associated with centralized pain (SS scale). The WPI assesses presence of pain in 19 designated body locations over the past 7 days (e.g., neck, right upper arm, left lower leg). Each location is equal to a score of 1. Items are summed to yield a total score, with higher scores indicating greater widespread pain. The six-item SS scale assesses (1) presence of clinical symptoms (lower abdomen pain, headache, depression) over the past 6 months and (2) the severity of cognitive symptoms (fatigue, trouble thinking or remembering, waking up tired/unrefreshed) over the past 7 days. Individuals are asked about whether they experience these symptoms generally, not specifically related to or as a consequence of their pain. The presence of a clinical symptom is equal to a score of 1. The severity of cognitive symptoms is scored on a 4-point scale where 0 indicates no problem and 3 indicates severe problem. Scores are calculated by summing items, with higher scores (out of a maximum score of 12) indicating greater symptom severity. The WPI and SS scales can be combined to create a total score (range 0–31), with higher scores indicating greater centralized pain features. The measure includes two additional questions that do not contribute to the overall score, the first assessing the chronicity of symptoms and the second determining whether symptoms are due to a pre-existing disorder. All participants completed the WPI and SS scale.

Body diagram

A previously validated self-report body diagram for youth was used to assess pain locations over the past 7 days in a subset of youth in the surgery sample.38 Youth indicated locations where they experienced aches or pain by drawing an “X” on a body outline showing the front and back of the body. The pain locations were coded into five regions in accordance with Jones et al.39 and based on the 1990 American College of Rheumatology definition of widespread pain: left side of body, right side of body, above waist (head, neck, arms, hands, upper body, chest, abdomen), below waist (lower abdomen/pelvis, low back, buttocks, legs, feet), and axial (spine, chest, or back), with the presence of pain in a region equal to a score of 1, for a total score out of 5.39,40 A single pain location could be coded into two regions (e.g., axial and below waist for low back pain). A total pain region score is calculated by summing the number of regions coded and categorizing the score into one of the following: two or fewer regions, three regions, four regions, and five regions. This coding scheme has been used in prior studies of pain distribution in youth.41

Pediatric Quality of Life Inventory

The Pediatric Quality of Life Inventory, Short Form version 4.0 (PedsQL) was used to assess health-related quality of life over the previous 4 weeks.42 The PedsQL contains 15 items; 10 assess the core domain of psychosocial functioning (e.g., “I feel sad or blue”) and 5 assess the core domain of physical function (e.g., “It’s hard for me to do sports activity or exercise”). Items are scored on a 5-point Likert scale, where 0 indicates never and 4 indicates almost always. The summary scores for each core domain are totaled and converted to a 0 to 100 point range, with higher scores indicating better health-related quality of life. The PedsQL has shown reliability and criterion and construct validity in healthy, chronically ill, and acutely ill youth.42 This measure was completed by the surgery and headache samples. Internal consistency was excellent for the physical health domain (α = 0.86) and the psychosocial health domain (α = 0.85).

Patient-Reported Outcomes Measurement Information System v2.0 Pediatric Profile–25

The sample with chronic pain completed the Patient-Reported Outcomes Measurement Information System Pediatric Profile instrument, a collection of short forms containing a total of 25 items from seven domains (pain intensity, pain interference, anxiety, depressive symptoms, fatigue, peer relationships, and physical function mobility). The measure assesses physical and psychosocial health and well-being in youth over the preceding 7 days. In the current study, we used the domains pain interference, physical function mobility, and pain intensity. The pain interference and physical function mobility domains both include four items. Items for pain interference are scored on a 5-point Likert scale where 1 indicates never and 5 indicates almost always. Items for physical function mobility are scored on a 5-point Likert scale where 1 indicates with no trouble and 5 indicates not able to do. For both domains, total raw scores are transformed into standardized T-scores for analyses. The T-score distribution has a mean of 50 (SD ± 10), with scores of more than one standard deviation higher or lower than the mean considered clinically meaningful. The Patient-Reported Outcomes Measurement Information System profile has been used in youth experiencing chronic pain.43,44 Internal consistency for the domains ranged from good (α = 0.75) to excellent (α = 0.93).

The pain intensity domain includes a single question, “How bad was your pain on average?” The question is scored using an 11-point numerical rating scale, with 0 indicating no pain and 10 indicating worst pain possible. Because this is a single item, it precludes reliability analysis.

Interviews to assess comprehension of the WPI and SS scale

A subset of participants (n = 11) were contacted by phone for comprehension interviews and asked to re-complete the WPI and SS online via Research Electronic Data Capture and to verbally indicate when they finished. Participants were then asked questions assessing comprehension of instructions and item comprehension (e.g., “What is this question asking?”; “In this question, what does ‘fatigue’ mean?”). Responses were coded dichotomously (yes/no) as to whether participants comprehended instructions and specific items. Adequate comprehension of instructions was defined as the ability to (1) describe in their own words what they needed to do to complete each item and (2) explain the meaning of the response options for all items (e.g., “slight or mild problem”). Adequate item comprehension was defined as the ability to interpret a series of five key words in the items (fatigue, widespread, intermittent, depression, disorder) identified by the research team as possibly exceeding the expected reading level of the sample.

Data analysis plan

All analyses were conducted with SPSS version 21.45 Missing data were minimal (8%). Youth in the surgery sample had more missing data because questionnaire items were presented as optional for this study only but were required for the headache and chronic pain samples. We found no demographic differences (e.g., age, sex, ethnicity, parent education) between the participants with versus without missing data. We therefore deemed that data were missing completely at random and used all available data in the analyses. We considered results statistically significant at P < 0.05. We report partial eta squared where appropriate, which is interpreted as follows: 0.01 = a small effect size, 0.06 = a medium effect size, and 0.14 = a large effect size.46 For correlational analyses, the size of r is interpreted as 0.1 =  small, 0.3 =  medium, and 0.5 =  large.47

The SS scale includes one item asking whether participants experienced a headache over the past 6 months. Given that this item could inflate results for the headache group, we ran the analyses twice: once with all items included and a second time with the headache item removed for the headache sample. Removal of the item did not change the magnitude or direction of the results; thus, we have presented the analyses with the headache item included.

Participant characteristics

We computed descriptive statistics for the sample demographics. We conducted t-tests to assess whether the WPI, SS scale, and total scores differed by sex and Pearson correlational analyses to determine differences by age. Based on related research into widespread pain and juvenile fibromyalgia, we expected higher WPI, SS scale, and total scores for older youth and females.30,31

Reliability

We assessed reliability of the SS scale through interitem and item total Pearson correlations and we assessed internal consistency (Cronbach’s alpha) of the three SS scale items scored on a continuous scale for the full sample. The WPI locations and the remaining three SS scale items are scored as dichotomous (yes/no) variables, which precluded analysis of internal consistency. Clark and Watson48 recommend mean interitem correlations within the range of 0.15 to 0.20 for scales measuring broad characteristics, such as headache, depression, and abdominal pain, and between 0.40 and 0.50 for scales measuring narrower characteristics, such as the cognitive symptom severity construct (fatigue, memory, tiredness). For item total correlations, a recommended cutoff point for retaining items is between r = 0.3048 and a more conservative r = 0.40.49

Validity

Construct validity

We conducted Pearson correlations to assess the relationship between the WPI, SS scale, and total scores with other measures of number of pain locations and child functioning. The domains included in the analyses were pain region, pain intensity, psychosocial health, physical health, pain interference, and physical function mobility.

Criterion validity

We investigated the validity of the measure to discriminate between groups that should, theoretically, have differing levels of features of centralized pain. Because we included three samples, we conducted analyses of variance (ANOVAs) and Bonferroni post hoc tests to compare WPI and SS scale and determine whether the measure showed expected differences between the samples. We expected higher WPI, SS scale, and total scores for youth with persistent pain conditions (chronic pain and headache groups).

Comprehension

Descriptive statistics were used to summarize the number of participants who demonstrated adequate comprehension of instructions and adequate item comprehension.

Results

Participant characteristics

Participant characteristics are presented in Table 1. There were no significant differences between the surgery, headache, or chronic pain samples on any of the demographic variables. There was a significant difference in pain intensity between the three samples; that is, youth with chronic pain reported significantly higher pain intensity than both other samples and youth with headache reported significantly higher pain intensity than the surgery sample. Item-level summary statistics for the SS scale are presented in Table 2.

Table 1.

Participant demographic characteristics (n = 240).

  Surgery sample Headache sample Chronic pain sample Whole sample Demographic differences
  n (%)a n (%) n (%) n (%)  
n 87 56 97 240  
Age, M (SD) 14.9 (1.9) 14.8 (1.9) 14.7 (1.8) 14.8 (1.9) F2,237 = 0.22, P = 0.80, η2 = 0.002b
Sex, female 60 (69.0) 40 (71.4) 80 (82.5) 180 (75.0) χ22 = 4.96, P = 0.08c
Race
White
African American
Asian
Other
Not reported
66 (75.9)
5 (5.7)
3 (3.4)
6 (6.8)
7 (8.0)
46 (82.1)
0
2 (3.6)
6 (10.7)
2 (3.6)
79 (81.4)
2 (2.1)
3 (3.1)
12 (12.3)
1 (1.0)
191 (79.6)
7 (2.9)
8 (3.3)
24 (10)
10 (4.2)
χ210 = 8.75, P = 0.56c
Ethnicity
Hispanic
Non-Hispanic
Unknown
Not reported
7 (8.0)
73 (83.9)
1 (1.1)
6 (6.9)
4 (7.1)
49 (87.5)
3 (5.4)
0
5 (5.2)
86 (88.7)
5 (5.2)
1 (1.0)
16 (6.7)
208 (86.7)
9 (3.8)
7 (2.9)
χ2 = 3.01, P = 0.56c
Parent education
High school or less
Vocational school/some college
College
Graduate/professional school
Not reported
14 (16.1)
21 (24.1)
35 (40.2)
13 (14.9)
4 (4.6)
2 (3.6)
16 (28.6)
24 (42.9)
14 (25.0)
0
12 (12.4)
29 (29.9)
35 (36.1)
18 (18.6)
3 (3.1)
28 (11.7)
66 (27.5)
94 (39.2)
45 (18.8)
7 (2.9)
χ26 = 7.37, P = 0.29c
Pain intensity, M (SD) 4.2 (1.5) 5.0 (1.9) 5.8 (1.8) 5.1 (1.8) F2,224 = 18.90, P <0.01, η2 = 0.15d

aAll percentages may not equal 100 due to rounding.

bANOVA (Mean age × Group)

cChi-square test (Dependent categorical variable [e.g., Sex] × Group).

dANOVA (Mean pain intensity × Group).

ANOVA = analysis of variance.

Table 2.

Symptom Severity scale item-level descriptives.

  Mean SD Rangea
Question 1: For each symptom listed below, use the following scale to indicate the severity of the symptom during the past 7 days.
Fatigue 1.2 1.0 0–3
Trouble thinking or remembering 0.9 0.9 0–3
Waking up tired 1.6 0.9 0–3
Question 2: During the past 6 months have you had any of the following symptoms?
    Yes, n (%)  
Pain or cramps in lower abdomen 131 (54.6)    
Depression 90 (37.5)    
Headaches 190 (79.82)    

aRange of participant responses (scale range 0–3); higher scores indicate greater symptom severity.

As hypothesized, females had higher WPI and total scores than males, indicating differences in widespread pain and overall features of centralized pain by sex (see Table 3). Contrary to our expectation, we did not identify statistically significant differences by sex for the SS scale. As hypothesized, we found greater WPI, SS scale, and total scores as youth increased in age, indicating that older children had greater features of pain centralization (WPI: r = 0.27, SS scale: r = 0.29, and total score: r = 0.32; all Ps 0.01).

Table 3.

Analyses of the WPI, SS scale, and total scores by sex.

  Malea Female Mean difference (SE)b 95% CI
WPI, M (SD) 2.9 (3.4) 4.9 (4.5) −2.02 (0.56) −3.12, −0.91*
SS scale, M (SD) 5.0 (2.5) 5.7 (2.8) −0.70 (0.41) −1.55, 0.15
Total score, M (SD) 8.1 (4.9) 10.8 (6.3) −2.66 (0.82) −4.29, −1.03*

aMale n = 60, female n = 180.

bMean difference was calculated as the first variable minus the second; thus, negative values indicate greater scores in females.

*P < 0.05.

WPI = Widespread Pain Index; SS = Symptom Severity; CI = confidence interval.

Reliability

We assessed reliability of the SS scale through internal consistency and interitem and item total correlations for the full sample (see Table 4). Internal consistency for cognitive symptoms was adequate (α = 0.70). Interitem analyses revealed small to large correlations with a range of r = 0.13 to 0.53. As expected from the literature,48 smaller correlations were seen between headache, depression, and abdominal pain items, and larger correlations were seen between the cognitive symptoms items. Item total correlations were medium to large with a range of r = 0.44 to 0.79. As hypothesized, all item total correlations were above the recommended cutoff point of r = 0.40,50 supporting reliability of the SS scale.

Table 4.

Symptom Severity scale interitem and item total Pearson (r) correlations.

  1 2 3 4 5 6
1. Fatigue            
2. Trouble thinking or remembering 0.37**          
3. Walking up tired (unrefreshed) 0.53** 0.42**        
4. Pain or cramps in the lower abdomen 0.19** 0.22** 0.23**      
5. Depression 0.28** 0.22** 0.29** 0.18**    
6. Headache 0.22** 0.25** 0.25** 0.21** 0.14*  
7. Total Symptom Severity scale 0.77** 0.71** 0.79** 0.45** 0.50** 0.44**

*P < 0.05. **P < 0.01.

Validity

Construct validity

To assess construct validity, we first evaluated associations between the WPI score and a body diagram to assess pain regions. As hypothesized, we found that a greater number of pain locations on the WPI was associated with a greater number of pain regions on the body diagram (r = 0.57, P < 0.01), and this was a large association.

Next, we evaluated associations between the SS scale and previously validated youth self-report measures of quality of life and pain interference. As expected, higher scores on the SS scale were associated with greater pain interference (r = 0.56, P < 0.01), lower psychosocial quality of life (r = −0.59, P < 0.01), and lower physical quality of life (r = −0.36, P < 0.01). These associations were moderate to large.

Third, we evaluated associations between the total score (WPI and SS scale combined) and measures of pain and function. As hypothesized, the total score was associated with a greater number of pain regions reported on the body diagram (r = 0.46, P < 0.01), higher pain intensity (r = 0.36, P < 0.01), and higher level of pain interference (r = 0.33, P < 0.01), as well as lower psychosocial quality of life (r = −0.51, P < 0.01), lower physical quality of life (r = −0.32, P < 0.01), and poorer physical function (r = −0.30, P < 0.01). These were moderate to large associations.

Criterion validity

Consistent with our hypothesis, we identified significant differences between our clinical samples on the WPI, SS scale, and total scores (see Table 5). Bonferroni post hoc tests revealed that the surgery sample had significantly lower WPI, SS scale, and total scores compared to the headache and chronic pain samples. As expected, we did not identify statistically significant differences between the headache and chronic pain groups on the WPI, SS scale, or total scores (all Ps > 0.05), indicating that both groups of youth with persistent pain had similar scores.

Table 5.

Analyses of the WPI, SS scale, and total scores by clinical population to assess criterion validity.

          Bonferroni post hoc analyses
  Surgery (1) Headache (2) Chronic pain (3) Group differencesa Mean difference (SE)b 95% CI
WPI, M (SD) 2.4 (2.0) 4.6 (3.8) 6.0 (5.4) F2,237 = 17.55, P < 0.001, η2 = 0.13 1:2 = −2.20 (0.70)
1:3 = −3.56 (0.60)
−3.89, −0.51*
−5.02, −2.11*
SS scale, M (SD) 3.6 (2.5) 6.6 (2.1) 6.3 (2.6) F2,222 = 33.09, P < 0.001, η2 = 0.23 1:2 = −3.04 (0.44)
1:3 = −2.72 (0.38)
−4.09, −1.98*
−3.63, −1.80*
Total score, M (SD) 6.5 (3.5) 11.2 (4.9) 12.3 (7.0) F2,222 = 23.74, P < 0.001, η2 = 0.18 1:2 = −4.73 (0.99)
1:3 = −5.78 (0.86)
−7.11, −2.35*
−7.86, −3.69*

aANOVA (Mean score × Group).

bMean difference was calculated as the first variable minus the second; thus, negative values indicate greater scores in headache and chronic pain samples.

*P < 0.001.

WPI = Widespread Pain Index; SS = Symptom Severity; CI = confidence interval; ANOVA = analysis of variance.

Understanding of the WPI and SS scale

Comprehension of instructions

All 11 participants interviewed (Mage = 15.8 years, range = 12.5–17.6, SD = 1.5; 73% female) met our criteria for adequate comprehension of the instructions for completing the WPI and SS scale.

Item comprehension

We found that participants were unable to demonstrate adequate comprehension of the following words from the SS scale: “depression” (incorrectly defined by three participants), “intermittent” (incorrectly defined by six participants), “fatigue” (unable to be defined by six participants), “widespread” (incorrectly defined by four participants), and “disorder” (unable to be defined by two participants). Participants either provided an incorrect interpretation of the above words or stated that they did not know what the word meant.

Discussion

The present study evaluated the psychometric properties of the WPI and SS scale in three pediatric samples with painful conditions. The SS scale showed reliability through adequate internal consistency and interitem and item total correlations. The measure showed good construct validity through expected relationships between the WPI and a body diagram and between the SS scale and measures of quality of life and pain interference. It also showed good criterion validity, with the WPI and SS scale discriminating between clinical groups hypothesized to have differing features of centralized pain. In terms of expected demographic differences, only the WPI performed as hypothesized, with older adolescents and females presenting with a higher number of pain locations, as assessed by the WPI. On the contrary, the SS scale did not demonstrate expected differences in centralized pain symptoms by sex. Further, comprehension of key items on the SS scale was problematic for some youth.

Several factors may have contributed to the SS scale performing contrary to hypotheses. The WPI and SS scale was originally developed to classify fibromyalgia in adults and, as such, the SS scale assesses the specific symptoms associated with adult fibromyalgia. Research shows that youth with juvenile fibromyalgia present with comorbid and related symptoms that are less pronounced than those reported by adults.30 In addition, there may be distinct clinical characteristics associated with centralized pain in youth that the measure does not assess. For example, anxiety/tension is associated with a number of chronic pain conditions in youth.5153 Difficulties with item comprehension may also have contributed to the performance of the SS scale. The SS scale does not include instructions on whether questions should be answered in relation to pain or in general, nor does it account for whether symptoms are a consequence of pain or a symptom of a comorbid condition (e.g., increased fatigue due to depression). Additionally, of concern, youth across the age range of 12 to 17 years demonstrated poor understanding of key terms used to assess symptoms (e.g., fatigue, depression). Similar difficulties with readability of the SS scale were found by Ting and colleagues29 when they examined diagnostic accuracy for fibromyalgia of the earlier 2010 version of the WPI and SS scale. Ting et al.29 recommended that problematic items might need to be amended for pediatric samples. However, we propose that further development of relevant items for assessment of symptoms associated with centralized pain in youth is needed.

Another potential limitation with applying this measure to populations other than those with fibromyalgia to assess features of centralized pain is that the WPI currently only includes pain locations relevant to fibromyalgia. The majority of our sample endorsed headaches on the SS scale, suggesting that this as a relevant pain location; however, the WPI does not currently include head pain. Since the development of the WPI (and our data collection commenced), a new measure of pain locations has been developed and is currently being used in conjunction with the SS scale to assess features of centralized pain in adult populations. The Michigan Body Map (MBM) includes the 19 areas from the WPI and another 16 locations (e.g., head, jaw, knee, ankle), allowing for broader research and greater clinical utility.54 It is similar to the WPI in that it is a continuous measure that allows for the spatial distribution of pain to be quantified. The MBM has shown good reliability when combined with the SS scale in adults,55 adequate validity to measure pain distribution, and good convergent validity with functional measures and was found to be preferable to the WPI by a sample of adults with pain.54 Thus, this may be a promising comprehensive measure to assess the spatial distribution of pain in youth as well. However, it is essential that the MBM undergo psychometric evaluation in pediatric samples before application to this population.

Relationships found in the present study between the WPI and SS scale and functional measures including physical and psychosocial health and pain interference support the notion that experiencing higher features of centralized pain can negatively affect important life domains. Prior work has examined the relationship between pain distribution, as indicated on body diagrams, and health and functional outcomes in youth in cross-sectional studies. In adolescents undergoing surgery, as well as those with acute and chronic pain conditions, widespread pain distribution was associated with poorer health-related quality of life and psychosocial health,41 greater school impairment,56 and reduced sleep quality.57 In a sample of adolescents with physical disabilities, greater pain distribution was associated with increased disability and decreased psychological function.58 Similarly, in youth with sickle cell disease, widespread pain was associated with increased pain intensity and burden, greater functional disability, impaired mood, and poorer quality of life.32 In a recent pediatric study in patients with idiopathic scoliosis,28 approximately one third of youth presented with pain profiles characterized by features of centralized pain (e.g., increased widespread pain, affective symptoms, fatigue). Following surgery, youth with more features of centralized pain reported higher acute pain intensity compared to those with fewer centralized pain features. In the longer term, youth with greater features of centralized pain reported higher chronic pain intensity, pain interference, and opioid use at 6 months following surgery.28 Together these studies suggest a potential longitudinal influence of central sensitization on pain outcomes, highlighting the importance of assessment of features of centralized pain in youth with painful conditions.

Future research and clinical implications

Pain features of location and spatial distribution are critical components of the ACTTION-American Pain Society Pain Taxonomy multidimensional framework, recommended for classifying both acute and chronic pain conditions, for application in research and clinical practice.17,18 The ACTTION-American Pain Society Pain Taxonomy distinguishes spatial distribution of pain as a distinct dimension from pain severity (intensity). Yet, in children and adolescents, much research attention has focused on measuring pain intensity.59 A critical barrier is the availability of valid and reliable measures to assess broader pain features, and the present study takes an important step by evaluating a measure of features of centralized pain in youth. In the clinical context, the WPI can be used to assess pain location and distribution, which should be interpreted alongside a physical exam, which includes assessment of sensory changes (i.e., allodynia and hyperalgesia). Comprehensive pain assessment provides critical information to inform a mechanisms-based approach to pain classification.8 Research will be needed to guide incorporation of centralized pain features in classification of acute and chronic pain in youth to guide management.

Limitations

The current study has several limitations. First, though inclusion of multiple clinical samples is a strength of the study, the clinical subgroups are small and the same data were not available for all youth. For example, only a subset of the surgery sample completed the body map, which was used in the analysis of construct validity of the WPI. Second, our sample lacked demographic and geographic diversity. Participants were predominately female and Caucasian, and all resided in the Pacific Northwest United States. Though our demographic characteristics are similar to those of other youth with painful conditions,60 as well as those who present for pediatric spinal surgery,28 they are not representative of the pediatric population overall. Third, we investigated associations between the WPI and SS scale and pain regions, intensity, and interference; however, other pain characteristics not captured, such as duration, could be important in assessing whether features of centralized pain develop over time (e.g., those with longer pain duration may have pain in more locations and greater associated symptoms). Fourth, our interviews were limited by a small sample size and unequal distribution across groups. However, the demographics of the sample interviewed were congruous with those of the full sample; thus, we expect limited deviation from our presented results with increased sample sizes. Finally, assessments of reliability were limited. We were not able to conduct test–retest reliability to assess the stability of the WPI and SS scale over time.

Conclusions

The WPI and SS scale assess the spatial distribution of pain and the severity of clinical symptoms associated with centralized pain. In the current study, the WPI showed sound psychometric properties in youth with painful conditions, with expected demographic differences, good construct and criterion validity, and comprehension by youth. However, the SS scale demonstrated issues with comprehension and was unable to demonstrate all expected differences between demographic groups. Our findings support the need for further work in developing psychometrically sound instruments for comprehensive assessment of pain in pediatric samples.

Funding Statement

This study was supported by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development under Award No. K23HD078239 (P.I.: J. Rabbitts) and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award No. K23NS089966 (P.I.: E. Law).

Disclosure statement

The authors have no conflicts of interest to declare.

References

  • 1.Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2–15. doi: 10.1016/j.pain.2010.09.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Graven-Nielsen T, Arendt-Nielsen L. Assessment of mechanisms in localized and widespread musculoskeletal pain. Nat Rev Rheumatol. 2010;6(10):599–606. doi: 10.1038/nrrheum.2010.107. [DOI] [PubMed] [Google Scholar]
  • 3.As-Sanie S, Harris RE, Harte SE, Tu FF, Neshewat G, Clauw DJ. Increased pressure pain sensitivity in women with chronic pelvic pain. Obstet Gynecol. 2013;122(5):1047–55. doi: 10.1097/AOG.0b013e3182a7e1f5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bouwense SA, de Vries M, Schreuder LT, Olesen SS, Frøkjær JB, Drewes AM, van Goor H, Wilder-Smith OH. Systematic mechanism-orientated approach to chronic pancreatitis pain. World J Gastroenterol. 2015;21(1):47–59. doi: 10.3748/wjg.v21.i1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bielefeldt K, Davis B, Binion DG. Pain and inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(5):778–88. doi: 10.1002/ibd.20848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Phillips K, Clauw DJ. Central pain mechanisms in the rheumatic diseases: future directions. Arthritis Rheum. 2013;65(2):291–302. doi: 10.1002/art.37739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience. 2016;338:114–29. doi: 10.1016/j.neuroscience.2016.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Fillingim RB, Loeser JD, Baron R, Edwards RR. Assessment of chronic pain: domains, methods, and mechanisms. J Pain. 2016;17(9 Suppl):10–20. doi: 10.1016/j.jpain.2015.08.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gwilym SE, Keltner JR, Warnaby CE, Carr AJ, Chizh B, Chessell I, Tracey I. Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Arthritis Rheum. 2009;61(9):1226–34. doi: 10.1002/art.24837. [DOI] [PubMed] [Google Scholar]
  • 10.Finan PH, Buenaver LF, Bounds SC, Hussain S, Park RJ, Haque UJ, Campbell CM, Haythornthwaite JA, Edwards RR, Smith MT. Discordance between pain and radiographic severity in knee osteoarthritis: findings from quantitative sensory testing of central sensitization. Arthritis Rheum. 2013;65(2):363–72. doi: 10.1002/art.34646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lee MC, Zambreanu L, Menon DK, Tracey I. Identifying brain activity specifically related to the maintenance and perceptual consequence of central sensitization in humans. J Neurosci. 2008;28:11642–49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Cornelissen L, Donado C, Kim J, Chiel L, Zurakowski D, Logan DE, Meier P, Sethna NF, Blankenburg M, Zernikow B, et al. Pain hypersensitivity in juvenile idiopathic arthritis: a quantitative sensory testing study. Pediatr Rheumatol Online J. 2014;12:39. doi: 10.1186/1546-0096-12-39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sherman AL, Morris MC, Bruehl S, Westbrook TD, Walker LS. Heightened temporal summation of pain in patients with functional gastrointestinal disorders and history of trauma. Ann Behav Med. 2015;49(6):785–92. doi: 10.1007/s12160-015-9712-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.King CD, Mano KE, Barnett KA, Pfeiffer M, Ting TV, Kashikar-Zuck S. Pressure pain threshold and anxiety in adolescent females with and without juvenile fibromyalgia: A Pilot Study. Clin J Pain. 2017;33(7):620–26. doi: 10.1097/AJP.0000000000000444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Akin-Akinyosoye K, Frowd N, Marshall L, Stocks J, Fernandes GS, Valdes A, McWilliams DF, Zhang W, Doherty M, Ferguson E, et al. Traits associated with central pain augmentation in the Knee Pain In the Community (KPIC) cohort. Pain. 2018;159(6):1035–44. doi: 10.1097/j.pain.0000000000001183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Brummett CM, Urquhart AG, Hassett AL, Tsodikov A, Hallstrom BR, Wood NI, Williams DA, Clauw DJ. Characteristics of fibromyalgia independently predict poorer long-term analgesic outcomes following total knee and hip arthroplasty. Arthritis Rheumatol. 2015;67(5):1386–94. doi: 10.1002/art.39051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Fillingim RB, Bruehl S, Dworkin RH, Dworkin SF, Loeser JD, Turk DC, Widerstrom-Noga E, Arnold L, Bennett R, Edwards RR, et al. The ACTTION-American Pain Society Pain Taxonomy (AAPT): an evidence-based and multidimensional approach to classifying chronic pain conditions. J Pain. 2014;15(3):241–49. doi: 10.1016/j.jpain.2014.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kent ML, Tighe PJ, Belfer I, Brennan TJ, Bruehl S, Brummett CM, Buckenmaier CC, Buvanendran A, Cohen RI, Desjardins P, et al. The ACTTION-APS-AAPM Pain Taxonomy (AAAPT) multidimensional approach to classifying acute pain conditions. Pain Med. 2017;18(5):947–58. doi: 10.1093/pm/pnx019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–10. doi: 10.1002/acr.20140. [DOI] [PubMed] [Google Scholar]
  • 20.Clauw DJ. Fibromyalgia: A clinical review. Jama. 2014;311(15):1547–55. doi: 10.1001/jama.2014.3266. [DOI] [PubMed] [Google Scholar]
  • 21.Lami MJ, Martínez MP, Miró E, Sánchez AI, Prados G, Cáliz R, Vlaeyen JW. Efficacy of combined cognitive-behavioral therapy for insomnia and pain in patients with fibromyalgia: A randomized controlled trial. Cognit Ther Res. 2018;42(1):63–79. doi: 10.1007/s10608-017-9875-4. [DOI] [Google Scholar]
  • 22.Lazaridou A, Kim J, Cahalan CM, Loggia ML, Franceschelli O, Berna C, Schur P, Napadow V. Edwards RR Effects of cognitive-behavioral therapy (CBT) on brain connectivity supporting catastrophizing in fibromyalgia. Clin J Pain. 2017;33(3):215–21. doi: 10.1097/AJP.0000000000000422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lumley MA, Schubiner H, Lockhart NA, Kidwell KM, Harte SE, Clauw DJ, Williams DA. Emotional awareness and expression therapy, cognitive behavioral therapy, and education for fibromyalgia: a cluster-randomized controlled trial. Pain. 2017;158(12):2354–63. doi: 10.1097/j.pain.0000000000001036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Wasserman RA, Brummett CM, Goesling J, Tsodikov A, Hassett AL. Characteristics of chronic pain patients who take opioids and persistently report high pain intensity. Reg Anesth Pain Med. 2014;39(1):13. doi: 10.1097/AAP.0000000000000024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Walters JL, Baxter K, Chapman H, Jackson T, Sethuramachandran A, Couldridge M, Joshi HR, Kundra P, Liu X, Nair D, et al. Chronic pain and associated factors in India and Nepal: A pilot study of the vanderbilt global pain survey. Anesth Analg. 2017;125(5):1616–26. doi: 10.1213/ANE.0000000000002360. [DOI] [PubMed] [Google Scholar]
  • 26.Brummett CM, Janda AM, Schueller CM, Tsodikov A, Morris M, Williams DA, Clauw DJ. Survey criteria for fibromyalgia independently predict increased postoperative opioid consumption after lower-extremity joint arthroplastya prospective, observational cohort study. Anesthesiology. 2013;119(6):1434–43. doi: 10.1097/ALN.0b013e3182a8eb1f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.de Tommaso M, Sciruicchio V, Delussi M, Vecchio E, Goffredo M, Simeone M, Barbaro MG. Symptoms of central sensitization and comorbidity for juvenile fibromyalgia in childhood migraine: an observational study in a tertiary headache center. J Headache Pain. 2017;18(1):59. doi: 10.1186/s10194-017-0764-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Voepel-Lewis T, Caird MS, Tait AR, Malviya S, Farley FA, Li Y, Abbott MD, van Veen T, Hassett AL, Clauw DJ. A high preoperative pain and symptom profile predicts worse pain outcomes for children after spine fusion surgery. Anesth Analg. 2017;124(5):1594–602. doi: 10.1213/ANE.0000000000001963. [DOI] [PubMed] [Google Scholar]
  • 29.Ting TV, Barnett K, Lynch-Jordan A, Whitacre C, Henrickson M, Kashikar-Zuck S. American College of Rheumatology adult fibromyalgia criteria for use in an adolescent female population with juvenile fibromyalgia. J Pediatr. 2010;2016:181–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kashikar-Zuck S, King C, Ting TV, Arnold LM. Juvenile fibromyalgia: different from the adult chronic pain Syndrome?. Curr Rheumatol Rep. 2016;18(4):19. doi: 10.1007/s11926-016-0569-9. [DOI] [PubMed] [Google Scholar]
  • 31.Mansfield KE, Sim J, Jordan JL, Jordan KP. A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population. Pain. 2016;157(1):55–64. doi: 10.1097/j.pain.0000000000000314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zempsky WT, Wakefield EO, Santanelli JP, New T, Smith-Whitley K, Casella JF, Palermo TM. Widespread pain among youth with sickle cell disease hospitalized with vasoocclusive pain: a different clinical phenotype?. Clin J Pain. 2017;33(4):335–39. doi: 10.1097/AJP.0000000000000403. [DOI] [PubMed] [Google Scholar]
  • 33.Clauw DJ. Diagnosing and treating chronic musculoskeletal pain based on the underlying mechanism(s). Best Prac Res Clin Rheumatol. 2015;29(1):6–19. doi: 10.1016/j.berh.2015.04.024. [DOI] [PubMed] [Google Scholar]
  • 34.Nahman-Averbuch H, Leon E, Hunter BM, Ding L, Hershey AD, Powers SW, King CD, Coghill RC. Increased pain sensitivity but normal pain modulation in adolescents with migraine. Pain. 2019;160(5):1019–28. doi: 10.1097/j.pain.0000000000001477. [DOI] [PubMed] [Google Scholar]
  • 35.Tham SW, Palermo TM, Holley AL, Zhou C, Stubhaug A, Furberg AS, Nielsen CS. A population-based study of quantitative sensory testing in adolescents with and without chronic pain. Pain. 2016;157(12):2807–15. doi: 10.1097/j.pain.0000000000000716. [DOI] [PubMed] [Google Scholar]
  • 36.Scher AI, Stewart WF, Lipton RB. The comorbidity of headache with other pain syndromes. Headache. 2006;46(9):1416–23. doi: 10.1111/j.1526-4610.2006.00584.x. [DOI] [PubMed] [Google Scholar]
  • 37.Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metdata-drive methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81. doi: 10.1016/j.jbi.2008.08.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Savedra MC, Tesler MD, Holzemer WL, Wilkie DJ, Ward JA. Pain location: validity and reliability of body outline markings by hospitalized children and adolescents. Res Nurs Health. 1989;12:307–14. [DOI] [PubMed] [Google Scholar]
  • 39.Jones GT, Silman AJ, Macfarlane GJ. Predicting the onset of widespread body pain among children. Arthritis Rheum. 2003;48(9):2615–21. doi: 10.1002/art.11221. [DOI] [PubMed] [Google Scholar]
  • 40.Wolfe F, Smythe HA, Yunus MB, Bennett RM, C B, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160–72. [DOI] [PubMed] [Google Scholar]
  • 41.Rabbitts JA, Holley AL, Groenewald CB, Palermo TM. Association between widespread pain Scores and functional impairment and health-related quality of life in clinical samples of children. J Pain. 2016;17(6):678–84. doi: 10.1016/j.jpain.2016.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800–12. [DOI] [PubMed] [Google Scholar]
  • 43.Bhandari RP, Feinstein AB, Huestis SE, Krane EJ, Dunn AL, Cohen LL, Kao MC, Darnall BD, Mackey SC. Pediatric-Collaborative Health Outcomes Information Registry (Peds-CHOIR): a learning health system to guide pediatric pain research and treatment. Pain. 2016;157(9):2033. doi: 10.1097/j.pain.0000000000000473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Noel M, Vinall J, Tomfohr-Madsen L, Holley AL, Wilson AC, Palermo TM. Sleep mediates the association between PTSD symptoms and chronic pain in youth. J Pain. 2018;19(1):67–75. doi: 10.1016/j.jpain.2017.09.002. [DOI] [PubMed] [Google Scholar]
  • 45.Ibm C. IBM SPSS Statistics for Windows. Armonk (NY): IBM Corp.; 2012. [Google Scholar]
  • 46.Cohen J. Statistical power analysis and research results. Am Educ Res J. 1973;10:225–29. [Google Scholar]
  • 47.Cohen J. Statistical power analysis for behavioral sceince-the effect size. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. [Google Scholar]
  • 48.Clark LA, Watson D. Constructing validity: basic issues in objective scale development. Psychol Assess. 1995;7(3):309. doi: 10.1037/1040-3590.7.3.309. [DOI] [Google Scholar]
  • 49.Field AP. Discovering statistics using SPSS. 2nd. London, UK: Sage; 2005. [Google Scholar]
  • 50.Ladhari R. Developing e-service quality scales: A literature review. J Retailing Consum Serv. 2010;17(6):464–77. doi: 10.1016/j.jretconser.2010.06.003. [DOI] [Google Scholar]
  • 51.Kashikar-Zuck S, Parkins IS, Graham TB, Lynch AM, Passo M, Johnston M, Schikler KN, Hashkes PJ, Banez G, Richards MM. Anxiety, mood, and behavioral disorders among pediatric patients with juvenile fibromyalgia syndrome. Clin J Pain. 2008;24(7):620–26. doi: 10.1097/AJP.0b013e31816d7d23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Pizolato RA, Freitas-Fernandes FS, Gaviao MB. Anxiety/depression and orofacial myofacial disorders as factors associated with TMD in children. Braz Oral Res. 2013;27:156–62. [DOI] [PubMed] [Google Scholar]
  • 53.Slater SK, Kashikar-Zuck SM, Allen JR, LeCates SL, Kabbouche MA, O’Brien HL, Hershey AD, Powers SW. Psychiatric comorbidity in pediatric chronic daily headache. Cephalalgia. 2012;32(15):1116–22. doi: 10.1177/0333102412460776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Brummett CM, Bakshi RR, Goesling J, Leung D, Moser SE, Zollars JW, Williams DA, Clauw DJ, Hassett AL. Preliminary validation of the Michigan Body Map (MBM). Pain. 2016;157(6):1205. doi: 10.1097/j.pain.0000000000000473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Nicol AL, Sieberg CB, Clauw DJ, Hassett AL, Moser SE, Brummett CM. The association between a history of lifetime traumatic events and pain severity, physical function, and affective distress in Patients with chronic pain. J Pain. 2016;17(12):1334–48. doi: 10.1016/j.jpain.2016.09.003. [DOI] [PubMed] [Google Scholar]
  • 56.Basch MC, Chow ET, Logan DE, Borsook D, Schechter NL, Simons LE. Cumulative effects of multiple pain sites in youth with chronic pain. Eur J Pain. 2018;22(6):1134–41. doi: 10.1002/ejp.1201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.de la Vega R, Racine M, Sánchez-Rodríguez E, Tomé-Pires C, Castarlenas E, Jensen MP, Miró J. Pain extent, pain intensity, and sleep quality in adolescents and young adults. Pain Med. 2016;17(11):1971–77. doi: 10.1093/pm/pnw118. [DOI] [PubMed] [Google Scholar]
  • 58.Miró J, de la Vega R, Tomé-Pires C, Sánchez-Rodríguez E, Castarlenas E, Jensen MP, Engel JM. Pain extent and function in youth with physical disabilities. J Pain Res. 2017;10:113–20. doi: 10.2147/JPR.S121590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.McGrath PJ, Walco GA, Turk DC, Dworkin RH, Brown MT, Davidson K, Eccleston C, Finley GA, Goldschneider K, Haverkos L, et al. Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: pedIMMPACT recommendations. J Pain. 2008;9(9):771–83. doi: 10.1016/j.jpain.2008.04.007. [DOI] [PubMed] [Google Scholar]
  • 60.King S, Chambers CT, Huguet A, MacNevin RC, McGrath PJ, Parker L, MacDonald AJ. The epidemiology of chronic pain in children and adolescents revisited: a systematic review. Pain. 2011;152(12):2729–38. doi: 10.1016/j.pain.2011.07.016. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Journal of Pain are provided here courtesy of Taylor & Francis

RESOURCES